The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test-Reference-Cited by-同舟云学术

The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test

Published:2016-02-19 Issue:2 Volume:11 Page:e0149230
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hametner Stephanie,Ferlitsch Arnulf,Ferlitsch Monika,Etschmaier Alexandra,Schöfl Rainer,Ziachehabi Alexander,Maieron Andreas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Measurement of portal pressure and its role in the management of chronic liver disease;J Bosch;Seminars in liver disease,2006

2. Noninvasive assessment of portal hypertension in patients with cirrhosis;D Thabut;Hepatology,2011

3. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension;R de Franchis;Journal of hepatology,2010

4. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis;C Ripoll;Journal of hepatology,2009

5. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II);M Peck-Radosavljevic;Wiener klinische Wochenschrift,2013

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis;Hepatology Research;2024-06-05

2. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient;Journal of Hepatology;2024-05

3. Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review;Medicina;2024-04-24

4. Non-Invasive versus Invasive Assessment of Portal Hypertension in Chronic Liver Disease;GE - Portuguese Journal of Gastroenterology;2024-04-22

5. Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension;PLOS ONE;2024-04-11